PRJNA834619
Human gut mycobiome raw sequence reads from patients with NAFLD and healthy controls
In this study, we explored and characterize the changes in the fungal community in the progression of non-alcoholic fatty liver disease (NAFLD), and we investigated if central antifungal immunity in NAFLD patients might be impaired and contribute to inflammatory disease properties. ITS1 data from NAFLD and healthy controls were analyzed.